Citation: | TAN Minyi, HU Yan, SONG Yanyan, ZENG Xia, GUI Zhaohuan, WU Shengchi, CHEN Yajun, CAI Li. Association between plasma Irisin concentrations and changes in blood pressure among children: a cohort study[J]. CHINESE JOURNAL OF SCHOOL HEALTH, 2023, 44(3): 419-422. doi: 10.16835/j.cnki.1000-9817.2023.03.023 |
[1] |
《中国心血管健康与疾病报告2020》编写组. 《中国心血管健康与疾病报告2020》要点解读[J]. 中国心血管杂志, 2021, 26(3): 209-218. doi: 10.3969/j.issn.1007-5410.2021.03.001
The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Interpretation of Report on Cardiovascular Health and Diseases in China 2020[J]. Chin J Cardiovasc Med, 2021, 26(3): 209-218. (in Chinese) doi: 10.3969/j.issn.1007-5410.2021.03.001
|
[2] |
马淑婧, 羊柳, 赵敏, 等. 1991—2015年中国儿童青少年血压水平及高血压检出率的变化趋势[J]. 中华高血压杂志, 2021, 41(2): 178-183.
MA S J, YANG L, ZHAO M, et al. Changing trends in the levels of blood pressure and prevalence of hypertension among Chinese children and adolescents from 1991 to 2015[J]. Chin J Epidemiol, 2021, 41(2): 178-183. (in Chinese)
|
[3] |
CHEN X L, WANG Y F. Tracking of blood pressure from childhood to adulthood: a systematic review and Meta-regression analysis[J]. Circulation, 2008, 117(25): 3171-3180. doi: 10.1161/CIRCULATIONAHA.107.730366
|
[4] |
BOSTROM P, WU J, JEDRYCHOWSKI M P, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis[J]. Nature, 2012, 481(7382): 463-468. doi: 10.1038/nature10777
|
[5] |
ZHANG L J, XIE Q, TANG C S, et al. Expressions of Irisin and urotensin Ⅱ and their relationships with blood pressure in patients with preeclampsia[J]. Clin Exp Hyperten, 2017, 39(5): 460-467. doi: 10.1080/10641963.2016.1273945
|
[6] |
YIN C Y, HU W, WANG M, et al. Irisin as a mediator between obesity and vascular inflammation in Chinese children and adolescents[J]. Nutr Metab Cardiovas, 2020, 30(2): 320-329. doi: 10.1016/j.numecd.2019.09.025
|
[7] |
CHEN K, ZHOU M D, WANG X M, et al. The role of myokines and adipokines in hypertension and hypertension-related complications[J]. Hyperten Res, 2019, 42(10): 1544-1551. doi: 10.1038/s41440-019-0266-y
|
[8] |
WU C Z, CHU N F, CHANG L C, et al. The relationship of Irisin with metabolic syndrome components and insulin secretion and resistance in schoolchildren[J]. Medicine, 2020, 100(5): e24061.
|
[9] |
JANG H B, KIM H J, KANG J H, et al. Association of circulating Irisin levels with metabolic and metabolite profiles of Korean adolescents[J]. Metabolism, 2017, 73: 100-108. doi: 10.1016/j.metabol.2017.05.007
|
[10] |
LIU C, WEI A L, WANG T H. Irisin, an effective treatment for cardiovascular diseases?[J]. J Cardiovasc Dev Dis, 2022, 9(9): 305. doi: 10.3390/jcdd9090305
|
[11] |
CAI L, TAN M Y, TAN W Q, et al. Associations of circulating Irisin concentrations with cardiometabolic risk factors among children vary by physical activity or sedentary time levels[J]. Front Endocrinol, 2019, 10: 549. doi: 10.3389/fendo.2019.00549
|
[12] |
LYU Y J, CAI L, GUI Z H, et al. Effects of physical activity and sedentary behaviour on cardiometabolic risk factors and cognitive function in children: protocol for a cohort study[J]. BMJ Open, 2019, 9(10): e030322. doi: 10.1136/bmjopen-2019-030322
|
[13] |
吕雅杰, 赖丽娟, 李丹玲, 等. 广州市小学生体质健康监测系统问卷的信效度研究[J]. 中国妇幼保健, 2020, 35(8): 1511-1516. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202008049.htm
LYU Y J, LAI L J, LI D L, et al. Study on the reliability and validity of physical health surveillance system questionnaire for primary school students in Guangzhou[J]. Matern Child Health Care Chin, 2020, 35(8): 1511-1516. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202008049.htm
|
[14] |
范晖, 闫银坤, 米杰. 中国3~17岁儿童性别、年龄别和身高别血压参照标准[J]. 中华高血压杂志, 2017, 25(5): 428-435.
FAN H, YAN Y K, MI J. Updating blood pressure references for Chinese children aged 3-17 years[J]. Chin J Hyperten, 2017, 25(5): 428-435. (in Chinese)
|
[15] |
HUO C J, YU X J, SUN Y J, et al. Irisin lowers blood pressure by activating the Nrf2 signaling pathway in the hypothalamic paraventricular nucleus of spontaneously hypertensive rats[J]. Toxicol Appl Pharm, 2020, 394: 114953. doi: 10.1016/j.taap.2020.114953
|
[16] |
HUANG Y, CHEN Q, JIANG Q, et al. Irisin lowers blood pressure in Zucker diabetic rats by regulating the functions of renal angiotensin Ⅱ type 1 receptor via the inhibition of the NF-κB signaling pathway[J]. Peptides, 2021, 147: 170688.
|
[17] |
FU J J, HAN Y, WANG J L, et al. Irisin lowers blood pressure by improvement of endothelial dysfunction via AMPK-Akt-eNOS-NO pathway in the spontaneously hypertensive rat[J]. J Am Heart Assoc, 2016, 5(11): e003433. doi: 10.1161/JAHA.116.003433
|
[18] |
MIAZGOWSKI T, MIAZGOWSKI B, KACZMARKIEWICZ A, et al. Associations of circulating Irisin with 24 h blood pressure, total and visceral fat, and metabolic parameters in young adult hypertensives[J]. Arch Endocrin Metab, 2021, 65(2): 137-143.
|
[19] |
LETICIA A B, GABRIELA B, TAIS S A, et al. Irisin-encoding gene (FNDC5) variant is associated with changes in blood pressure and lipid profile in type 2 diabetic women but not in men[J]. Metabolism, 2015, 64(9): 952-957. doi: 10.1016/j.metabol.2015.05.005
|
[20] |
WANG H D, WANG X J, CAO Y, et al. Association of polymorphisms of preptin, Irisin and adropin genes with susceptibility to coronary artery disease and hypertension[J]. Medicine(Baltimore), 2020, 99(10): e19365-e19365.
|
[21] |
LAVIE C J, OZEMEK C, CARBONE S, et al. Sedentary behavior, exercise, and cardiovascular health[J]. Circ Res, 2019, 124(5): 799-815.
|
[22] |
DURAN A T, ROMERO E, DIAZ K M. Is sedentary behavior a novel risk factor for cardiovascular disease?[J]. Curr Cardiol Rep, 2022, 24(4): 393-403.
|
[23] |
ANTONIO G H, IGNACIO H A, NICOLE G C, et al. Exercise program and blood pressure in children: the moderating role of sedentary time[J]. J Sci Med Sport, 2020, 23(9): 854-859.
|